Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 18, 2021

Primary Completion Date

December 16, 2024

Study Completion Date

July 28, 2025

Conditions
Renal Cell Carcinoma
Interventions
BIOLOGICAL

donor FMT

This intervention is represented by the administration, in the recipients' gut, of donor microbiota through FMT

OTHER

Placebo FMT

This intervention is represented by the administration, in the recipients' gut, of a placebo through FMT

Trial Locations (2)

00168

Digestive Disease Center, Rome

Gianluca Ianiro, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04758507 - Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter